Insights On Trial Design
-
Human Abuse Potential: Study Management
5/1/2026
Strengthen your human abuse potential studies through thoughtful, targeted volunteer selection, with clearly defined inclusion and exclusion criteria, and disciplined study oversight.
-
Early Immune Profiling With In Vivo, In Vitro, And Ex Vivo Systems
10/7/2025
Modern biologics increasingly interact with the immune system. While these innovations enable transformative therapies, they can also provoke acute immune activation during first-in-human (FIH) trials.
-
Virtual Clinical Trials For Ophthalmic Measures
12/4/2025
Remote ophthalmic assessments such as BCVA, OCT, and IOP expand trial access and efficiency, preserving data quality while reducing site burden and boosting patient engagement.
-
Practical ICH E6(R3) Oversight For Your Centralized Monitoring Strategy
3/17/2026
Bridge the gap between fragmented data and ICH E6(R3) compliance. Learn to use unified data signals to catch consent errors and enrollment delays before they trigger audit findings.
-
A New Blueprint For Transforming Feasibility And Recruitment
9/22/2025
Discover how a connected approach links feasibility and recruitment, using real-world data to design realistic protocols, reach the right patients, and accelerate enrollment with confidence.
-
Is Your Clinical Research Site GCP-Ready?
4/9/2025
By fostering a culture of continuous improvement through internal audits, clinical research sites can identify non-compliance issues and enhance their research practices.
-
Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk
2/24/2026
Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.
-
Cell And Gene Therapy For Enhanced CNS And Ocular Delivery In Nonhuman Primates
2/20/2025
Gain valuable insights into the cutting-edge approaches shaping the future of gene and cell therapy delivery, ensuring more effective and efficient translation from discovery to clinical application.
-
Biotech Landscape Continues To Shift
9/18/2025
Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.
-
Accelerating Early Phase Oncology Study Development
4/17/2025
Explore a close collaboration to co-develop a comprehensive, adaptive protocol designed to support key decisions across multiple trial phases for an innovative cancer therapy.